Medinice SA (ICEP)

Currency in PLN
62.50
+1.70(+2.80%)
Closed·
ICEP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
57.4063.40
52 wk Range
6.7465.30
Key Statistics
Bid/Ask
61.10 / 63.90
Prev. Close
62.5
Open
62
Day's Range
57.4-63.4
52 wk Range
6.74-65.3
Volume
93.76K
Average Volume (3m)
113.45K
1-Year Change
676.3975%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ICEP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Medinice S.A., a medical technology company, creates, develops, and commercializes minimally invasive solutions in cardiology and cardiac surgery. The company offers PacePress, a medical device to reduce the risk of complications following the implantation of cardiac electrotherapeutic devices, such as pacemakers or implantable cardioverter-defibrillators; CoolCryo, a cardiac cryoablation technology that uses liquid nitrogen as the cooling medium; and AtriClamp, a clip designed to close the left atrial appendage to minimize the risk of stroke in patients with atrial fibrillation. It also provides MiniMax, an ablation-mapping catheter used for detecting intracardiac electrophysiological signals, creating a 3D map of the heart, and performing intracardiac irrigated RF ablation to treat arrhythmias caused by abnormalities in the heart’s conduction system; and EP Bioptom, an electrode for endomyocardial biopsy using 3D mapping enabling simultaneous biopsy and creation of a three-dimensional heart map. The company was founded in 2012 and is headquartered in Warsaw, Poland.

Compare ICEP to Peers and Sector

Metrics to compare
ICEP
Peers
Sector
Relationship
P/E Ratio
−86.3x−8.6x−0.5x
PEG Ratio
0.750.020.00
Price/Book
6.6x1.8x2.6x
Price / LTM Sales
-6.1x3.2x
Upside (Analyst Target)
-54.2%44.7%
Fair Value Upside
Unlock6.7%5.7%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
18/03/2026
EPS / Forecast
-0.49 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ICEP Income Statement

People Also Watch

298.00
SNTP
-1.65%
661.00
CRI1
-0.30%
1.8600
GVTP
+0.11%
462.00
SCW
+1.54%
59.70
ASBP
+0.67%

FAQ

What Is the Medinice (ICEP) Stock Price Today?

The Medinice stock price today is 62.50 PLN.

What Stock Exchange Does Medinice Trade On?

Medinice is listed and trades on the Warsaw Stock Exchange.

What Is the Stock Symbol for Medinice?

The stock symbol for Medinice is "ICEP."

What Is the Medinice Market Cap?

As of today, Medinice market cap is 580.41M PLN.

What Is Medinice's Earnings Per Share (TTM)?

The Medinice EPS (TTM) is -0.86.

When Is the Next Medinice Earnings Date?

Medinice will release its next earnings report on 08/05/2026.

From a Technical Analysis Perspective, Is ICEP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Medinice Stock Split?

Medinice has split 0 times.

What is the current trading status of Medinice (ICEP)?

As of 21/04/2026, Medinice (ICEP) is trading at a price of 62.50 PLN, with a previous close of 62.50 PLN. The stock has fluctuated within a day range of 57.40 PLN to 63.40 PLN, while its 52-week range spans from 6.74 PLN to 65.30 PLN.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.